Hypoxia-inducible factor-proline dioxygenase (EC 1.14.11.29, HIF hydroxylase) is an enzyme with systematic name hypoxia-inducible factor-L-proline, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating). This enzyme catalyses the following chemical reaction hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO2 Hypoxia-inducible factor-proline dioxygenase contains iron, and requires ascorbate.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Hypoxia-inducible factor-proline dioxygenase (en)
- 缺氧誘導因子脯胺酸羥化酶 (zh)
|
rdfs:comment
| - HIF脯胺酸羥化酶(英語:HIF prolyl-hydroxylase)是一個包含在缺氧誘導因子(英語:Hypoxia-inducible factor,简称:HIF)訊息路徑中的酶,也是一系列稱為HIF脯胺酸羥化酶抑制劑 治療性藥物的目標 缺氧誘導因子(HIF)是一個在演化上被保留下來的轉錄因子,它讓細胞可以針對低氧濃度環境作出生理性的反應。其中一種特定作用在HIF上的脯胺酸羥化酶已經被確認存在;而羥基化的HIF能讓蛋白質被作為降解的目標 HIF脯胺酸羥化酶已經被各式各樣抑制劑作為目標,用來治療中風,腎臟疾病缺血,贫血,和其他重大疾病。在紅血球過多症相關以及乳癌相關的PHD2突變的案例中,臨床觀察下的脯胺酸羥化酶區域突變會影響它對HIF受質的選擇性,這點對藥物設計有重要的意義。在人體中,HIF脯胺酸雙氧化酶有三種種型。分別是 PHD1、PHD2和PHD3。其中,PHD2因為它對氧氣緩慢的反應速度而被視為人體最重要的氧氣感應器。 (zh)
- Hypoxia-inducible factor-proline dioxygenase (EC 1.14.11.29, HIF hydroxylase) is an enzyme with systematic name hypoxia-inducible factor-L-proline, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating). This enzyme catalyses the following chemical reaction hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO2 Hypoxia-inducible factor-proline dioxygenase contains iron, and requires ascorbate. (en)
|
foaf:name
| - Hypoxia-inducible factor-proline dioxygenase (en)
|
name
| - Hypoxia-inducible factor-proline dioxygenase (en)
|
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
EC number
| |
IUBMB EC number
| |
has abstract
| - Hypoxia-inducible factor-proline dioxygenase (EC 1.14.11.29, HIF hydroxylase) is an enzyme with systematic name hypoxia-inducible factor-L-proline, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating). This enzyme catalyses the following chemical reaction hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO2 Hypoxia-inducible factor-proline dioxygenase contains iron, and requires ascorbate. Hypoxia-inducible factor (HIF) is an evolutionarily conserved transcription factor that allows the cell to respond physiologically to low concentrations of oxygen. A class of prolyl hydroxylases which act specifically on HIF has been identified; hydroxylation of HIF allows the protein to be targeted for degradation. HIF prolyl-hydroxylase has been targeted by a variety of inhibitors that aim to treat stroke, kidney disease, ischemia, anemia, and other important diseases. Clinically observed prolyl hydroxylase domain mutations, as in the case of erythrocytosis- and breast cancer-associated PHD2 mutations, affect its selectivity for its HIF substrate, which has important implication for drug design. In humans, there are three isoforms of hypoxia-inducible factor-proline dioxygenase. These are PHD1, PHD2 and PHD3. PHD2, in particular, was identified as the most important human oxygen sensors due to its slow reaction with oxygen. (en)
- HIF脯胺酸羥化酶(英語:HIF prolyl-hydroxylase)是一個包含在缺氧誘導因子(英語:Hypoxia-inducible factor,简称:HIF)訊息路徑中的酶,也是一系列稱為HIF脯胺酸羥化酶抑制劑 治療性藥物的目標 缺氧誘導因子(HIF)是一個在演化上被保留下來的轉錄因子,它讓細胞可以針對低氧濃度環境作出生理性的反應。其中一種特定作用在HIF上的脯胺酸羥化酶已經被確認存在;而羥基化的HIF能讓蛋白質被作為降解的目標 HIF脯胺酸羥化酶已經被各式各樣抑制劑作為目標,用來治療中風,腎臟疾病缺血,贫血,和其他重大疾病。在紅血球過多症相關以及乳癌相關的PHD2突變的案例中,臨床觀察下的脯胺酸羥化酶區域突變會影響它對HIF受質的選擇性,這點對藥物設計有重要的意義。在人體中,HIF脯胺酸雙氧化酶有三種種型。分別是 PHD1、PHD2和PHD3。其中,PHD2因為它對氧氣緩慢的反應速度而被視為人體最重要的氧氣感應器。 (zh)
|
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
EC number
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |